Boston Scientific study shows benefits of long-term spinal cord stimulation

Boston Scientific has announced the findings of a new clinical study showing the pain relief benefits of long-term spinal cord stimulation (SCS) therapy.

Data from the WHISPER trial has shown that patients who are given the choice to use both sub-perception and paresthesia-based SCS therapy generally achieved superior outcomes compared to those given only one option.

When given this choice, the number of subjects whose pain was effectively controlled by SCS increased by 62 percent, while 57 percent of patients were shown to prefer the option of both sub-perception and paresthesia-based therapy.

Maulik Nanavaty, president and senior vice-president for neuromodulation at Boston Scientific, said: "We are dedicated to improving the lives of patients with industry-leading neuromodulation technology designed for long-lasting relief."

SCS works by sending low electrical pulses to the spinal cord to interrupt pain signals and provide pain relief. Paresthesia-based therapy delivers these benefits alongside a light tingling sensation, while sub-perception therapy works without that sensation.

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.